Aehr director trust sells 30,000 shares at $70
Aehr Test Systems director Rhea J. Posedel, through a trust, sold 30,000 shares of common stock in an open-market transaction at $70.00 per share on April 9, 2026.
Rhea-AI Filing Summary
Aehr Test Systems director Rhea J. Posedel, through a trust, sold 30,000 shares of common stock in an open-market transaction at $70.00 per share on April 9, 2026. After this sale, the trust still holds 426,979 shares indirectly, and Posedel also holds 71,163 shares directly. The indirect holdings include shares subject to unvested restricted stock units, indicating a continuing equity stake tied to ongoing service or vesting conditions.
Positive
- None.
Negative
- None.
Insights
Director’s trust sells 30,000 shares while keeping a substantial remaining stake.
Director Rhea J. Posedel executed an open-market sale of 30,000 Aehr Test Systems common shares at $70.00 per share via a trust. This is a straightforward disposition with no derivatives exercised in this filing.
Post-transaction, the trust still holds 426,979 shares indirectly, and Posedel also owns 71,163 shares directly. The filing notes that indirect holdings include unvested restricted stock units, underscoring an ongoing, incentive-based equity position despite the sale.
Given the sizable remaining ownership and absence of derivative activity or other complex structures in this excerpt, the transaction appears as a routine liquidity event by a large existing holder rather than a transformative change in ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,000 | $70.00 | $2.10M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The amount reported includes shares subject to unvested restricted stock units.
Key Figures
Key Terms
open-market sale financial
indirect ownership financial
restricted stock units financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AEHR director Rhea J. Posedel report?
Was the AEHR insider sale an open-market transaction?
Are any of Rhea J. Posedel’s AEHR holdings subject to vesting conditions?
How does the AEHR Form 4 distinguish direct and indirect ownership for this insider?
AI-generated analysis. How Rhea-AI works. Not financial advice.